Primary lung secretory carcinoma: a case report
Huihua Li, Darya Buehler, Jefree J. Schulte
Precision Oncology Tumor Board
Trastuzumab-Pertuzumab resistance in a case of HER2-del16 expressing colorectal cancer—a case report
Trastuzumab-Pertuzumab resistance in a case of HER2-del16 expressing colorectal cancer—a case report
Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Exploiting homologous recombination repair alterations in metastatic castrate-resistant prostate cancer: a case report and literature review
Exploiting homologous recombination repair alterations in metastatic castrate-resistant prostate cancer: a case report and literature review
Utilizing genomic profiling in a patient with a thoracic malignancy of uncertain primary: case report
Utilizing genomic profiling in a patient with a thoracic malignancy of uncertain primary: case report
Targeting EGFR mutations needs to be more precise with co-mutations
Targeting EGFR mutations needs to be more precise with co-mutations
Precision medicine: BRAF mutations in thyroid cancer
Amanda Podolski, Enrico Castellucci, Balazs Halmos
Cancer diagnosis after solid organ transplantation: do we need to know the cell of origin?
Karine Darbinyan, Changcheng Zhu, Scott Scheinin, Harish Seethamraju, Balazs Halmos
Targeting ErbB2 aberrations in non-small cell lung cancer
Xuan Ge, Sara Tariq, Haiying Cheng, Balazs Halmos
Precision Oncology Tumor Board—a new series to facilitate a global dialogue
Balazs Halmos, MD
Disclosure:
The series “Precision Oncology Tumor Board” was commissioned by the editorial office, Precision Cancer Medicine without any sponsorship or funding. Balazs Halmos served as the unpaid Guest Editor for the series.